How Did We Get a COVID-19 Vaccine in Less Than 1 Year?
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 33542081.
- Also identified by DOI 10.1158/1078-0432.CCR-21-0079 and PMC identifier 8052930.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The successful development of COVID-19 vaccines within an unprecedented short time needs to be followed by rapid vaccine uptake, in particular, in high-risk populations such as patients with cancer. It is important for the scientific research community and cancer physicians to convey the knowledge behind the COVID-19 vaccine development and contribute to build the required trust on their use.
Medical subject headings
- COVID-19
- COVID-19 Vaccines
- SARS-CoV-2
- Vaccination